We showed that Artemisinin transcriptionally repressed FoxM1 and its downstream targets by intervening with its trans-activation ability in HCC cells, thereby blocking the deregulated expression of its pro-oncogenic downstream molecules. The gene discussed is FOXM1; the disease is hepatocellular carcinoma.